Family Office
‘Biotech is the ultimate impact investment’ — family offices can’t get enough of it
he Lauber family built its wealth in real estate, and that’s where it stayed for decades. But, lately, some of the family money has a buzzy new destination: biotech. “I’m kind of like a hypochondriac,” says Robin Lauber, the third-generation heir who is diversifying the Swiss family’s wealth, mainly into…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: Financial Times